<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33461632</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>149</Volume><PubDate><Year>2021</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.</ArticleTitle><Pagination><StartPage>e32</StartPage><MedlinePgn>e32</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e32</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268821000145</ELocationID><Abstract><AbstractText>Bergamo province was badly hit by the coronavirus disease 2019 (COVID-19) epidemic. We organised a public-funded, multidisciplinary follow-up programme for COVID-19 patients discharged from the emergency department or from the inpatient wards of 'Papa Giovanni XXIII' Hospital, the largest public hospital in the area. As of 31 July, the first 767 patients had completed the first post-discharge multidisciplinary assessment. Patients entered our programme at a median time of 81 days after discharge. Among them, 51.4% still complained of symptoms, most commonly fatigue and exertional dyspnoea, and 30.5% were still experiencing post-traumatic psychological consequences. Impaired lung diffusion was found in 19%. Seventeen per cent had D-dimer values two times above the threshold for diagnosis of pulmonary embolism (two unexpected and clinically silent pulmonary thrombosis were discovered by investigating striking D-dimer elevation). Survivors of COVID-19 exhibit a complex array of symptoms, whose common underlying pathology, if any, has still to be elucidated: a multidisciplinary approach is fundamental, to address the different problems and to look for effective solutions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Venturelli</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5679-2516</Identifier><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benatti</LastName><ForeName>Simone Vasilij</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casati</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuglian</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione IRCSS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imeri</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biffi</LastName><ForeName>Ave Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spada</LastName><ForeName>Maria Simonetta</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bondi</LastName><ForeName>Emi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camera</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severgnini</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giammarresi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinaro</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossini</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4769-0729</Identifier><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonaffini</LastName><ForeName>Pietro Andrea</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellasi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesa</LastName><ForeName>Simonetta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-acute</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>All the authors report no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>19</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33461632</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pii">S0950268821000145</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Source: ISTAT, 4th of May 2020, Impatto dell'epidemia COVID-19 sulla mortalit&#xe0; totale della popolazione residente primo trimestre 2020. https://www.istat.it/it/files/2020/05/Rapporto_Istat_ISS.pdf (Accessed 11 September 2020).</Citation></Reference><Reference><Citation>Wiersinga WJ et al. (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Journal of the American Medical Association 324, 782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. British Medical Journal 369, m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Duca A et al. (2020) Severity of respiratory failure and outcome of patients needing a ventilatory support in the emergency department during Italian novel coronavirus SARS-CoV2 outbreak: preliminary data on the role of helmet CPAP and non-invasive positive pressure ventilation. EClinicalMedicine 24, 100419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301102</ArticleId><ArticleId IdType="pubmed">32766538</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R and Landi F (2020) Persistent symptoms in patients after acute COVID-19. Journal of the American Medical Association 324, 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T et al. (2020) Management of post-acute covid-19 in primary care. British Medical Journal 370, m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ et al. (2021) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. Journal of Medical Virology 93, 1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell E. Living with Covid19, Themed Review, by the National Institute for Health Research (NIHR), United Kingdom. Published: 15 October 2020. doi: 10.3310/themedreview_41169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_41169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleat D, Wain R and Miller B. Long Covid: Reviewing the Science and Assessing the Risk. Publication by the Tony Blair Institute for Global Change, London, 5th October 2020; https://institute.global/policy/long-covid-reviewing-science-and-assessing-risk (Accessed 4 January 2021).</Citation></Reference><Reference><Citation>Lamas D (2020) Building an evidence base for survivors of critical illness. New England Journal of Medicine 383, 1067&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">32905682</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC and Girard TD (2020) Recovery from severe COVID-19: leveraging the lessons of survival from sepsis. Journal of The American Medical Association 324, 739&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">32777028</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D et al. (2020) Long-term consequences of COVID-19: research needs. The Lancet Infectious Diseases 20, 1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Craparo G et al. (2013) The impact of event scale &#x2013; revised: psychometric properties of the Italian version in a sample of flood victims. Neuropsychiatric Disease and Treatment 9, 1427&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788700</ArticleId><ArticleId IdType="pubmed">24092980</ArticleId></ArticleIdList></Reference><Reference><Citation>Altamore F et al. (2020) Psychological symptoms and quality of life after repeated exposure to earthquake: a cohort study in Italy. PLoS One 15, e0233172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217461</ArticleId><ArticleId IdType="pubmed">32396568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BYQ et al. (2020) Psychological impact of the COVID19 pandemic on health care workers in Singapore. Annals of Internal Medicine 173, 317&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143149</ArticleId><ArticleId IdType="pubmed">32251513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C et al. (2020) A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain, Behavior and Immunity 87, 40&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153528</ArticleId><ArticleId IdType="pubmed">32298802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C et al. (2020) Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. International Journal of Environmental Research and Public Health 17, 1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084952</ArticleId><ArticleId IdType="pubmed">32155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K et al. (2020) Applying the WHO ICF framework to the outcome measures used in the evaluation of long-term clinical outcomes in coronavirus outbreaks. International Journal of Environmental Research and Public Health 17, 6476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7558385</ArticleId><ArticleId IdType="pubmed">32899534</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM et al. (2017) Core outcome measures for clinical research in acute respiratory failure survivors. An international modified Delphi consensus study. American Journal of Respiratory and Critical Care Medicine 196, 1122&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5694837</ArticleId><ArticleId IdType="pubmed">28537429</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS and Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67, 361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sel&#xe7;uk &#xd6; and &#x15e;&#xfc;kriye B&#xd6; (2020) Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. International Journal of Social Psychiatry 66, 504&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405629</ArticleId><ArticleId IdType="pubmed">32380879</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthar SS (2006) Resilience in development: a synthesis of research across five decades In Cicchetti D and Cohen DJ (eds), Developmental Psychopathology: Risk, Disorder, and Adaptation. Hoboken, NJ: John Wiley &amp; Sons, pp. 739&#x2013;795.</Citation></Reference><Reference><Citation>Friborg O et al. (2003) A new rating scale for adult resilience: what are the central protective resources behind healthy adjustment? International Journal of Methods in Psychiatric Research 12, 65&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6878238</ArticleId><ArticleId IdType="pubmed">12830300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatric Society 53, 695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Santangelo G et al. (2015) Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurological Sciences 36, 585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">25380622</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeoto G et al. (2015) The Barthel Index: Italian translation, adaptation and validation. International Journal of Neurology and Neurotherapy 2, 028.</Citation></Reference><Reference><Citation>Castiglia SF et al. (2017) The culturally adapted Italian version of the Barthel Index (IcaBI): assessment of structural validity, inter-rater reliability and responsiveness to clinically relevant improvements in patients admitted to inpatient rehabilitation centers. Functional Neurology 22, 221&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5762108</ArticleId><ArticleId IdType="pubmed">29306359</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuman-Paretsky MJ et al. (2014) Psychometric properties of the brief fatigue inventory in community-dwelling older adults. Archives of Physical Medicine and Rehabilitation 95, 1533&#x2013;1539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4124821</ArticleId><ArticleId IdType="pubmed">24742938</ArticleId></ArticleIdList></Reference><Reference><Citation>Catania G et al. (2013) Cancer-related fatigue in Italian cancer patients: validation of the Italian version of the brief fatigue inventory (BFI). Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 21, 413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">22790224</ArticleId></ArticleIdList></Reference><Reference><Citation>Regione Lombardia, Deliberazione n&#xb0; XI/ 3326, seduta del 30/06/2020, Oggetto: Disposizione per la gestione dell'emergenza sanitaria da COVID-19 &#x2013; Esenzione P01 e nuova esenzione regionale D97. https://www.regione.lombardia.it/wps/wcm/connect/63101b09-a82e-45dd-86b0-24ae1655f993/dgr+3326+2020.pdf?MOD=AJPERES&amp;CACHEID=ROOTWORKSPACE-63101b09-a82e-45dd-86b0-24ae1655f993-ncB6QUh (Accessed 11 September 2020).</Citation></Reference><Reference><Citation>Townsend L et al. (2020) Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 15, e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A et al. Multi-organ impairment in low-risk individuals with long COVID. Pre-print on medRxiv 2020.10.14.20212555. 10.1101/2020.10.14.20212555 (Accessed 4 January 2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.14.20212555</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---21-august-2020 (Accessed 4 January 2021).</Citation></Reference><Reference><Citation>Raman B et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. Pre-print on medRxiv 2020.10.15.20205054. 10.1101/2020.10.15.20205054 (Accessed 4 January 2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.15.20205054</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. (2020) Follow-up of adults with non-critical COVID-19 two months after symptoms' onset. Clinical Microbiology and Infection; S1198-743X(20)30606-6. Published online ahead of print: 5 October 2020. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Noris M, Benigni A and Remuzzi G (2020) The case of complement activation in COVID-19 multi-organ impact. Kidney International 98, 314&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7246017</ArticleId><ArticleId IdType="pubmed">32461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R, et al. (2020) Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 61, 103104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>